Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Request for the Technical Review of 25 Draft Skin Notation Assignments and Skin Notation Profiles

November 2013
NIOSH Docket Number 153-B, CDC-2013-0022

In 2009, NIOSH published the Current Intelligence Bulletin (CIB) 61 – A Strategy for Assigning New NIOSH Skin Notations [NIOSH 2009-147;]. This strategy involves the assignment of multiple skin notations for distinguishing systemic, direct, and sensitizing effects caused by exposure of skin to chemicals. Historically, skin notations have been published in the NIOSH Pocket Guide to Chemical Hazards [NIOSH 2005-149], and this practice will continue for each evaluated chemical. The Skin Notation Profile for a chemical is intended to provide information supplemental to the skin notation, including a summary of all relevant data used to aid in determining the hazards associated with skin exposures.

To view the notice and related materials, visit and enter CDC-2013-0022 in the search field and click "Search."

Federal Register Notice:

Federal Register Notice: 70047 [PDF - 206KB]

Document # Substance(s)
B-01 Allyl glycidyl ether (CAS# 108-92-3)
B-02 2-Diethylaminoethanol (CAS# 100-37-8)
B-03 Methyl isocyanate(CAS# 624-83-9)
B-04 2-Ethoxyethyl acetate (CAS# 111-15-9)
B-05 Propargyl alcohol (CAS# 107-19-7)
B-06 Ethyl acrylate (CAS# 140-88-5)
B-07 Isophorone diisocyanate (CAS# 4098-71-9)
B-08 Nitrobenzene (CAS# 98-95-3)
B-09 Phenylhydrazine (CAS# 100-63-0)
B-10 2-Mercaptobenzothiazole (CAS# 149-30-4)
B-11 Aniline (CAS# 62-53-3)
B-12 Captafol (CAS# 2425-06-1)
B-13 Dinitro-o-cresol (CAS# 534-52-1)
B-14 Aldrin (CAS# 309-00-2)
B-15 Dieldrin (CAS# 60-57-1)
B-16 Parathion (CAS# 56-38-2)
B-17 Nicotine (CAS# 54-11-5)
B-18 Azinphos-methyl (CAS# 86-50-0)
B-19 Endrin (CAS# 72-20-8)
B-20 Methyl parathion (CAS# 298-00-0)
B-21 Phorate (CAS# 298-02-2)
B-22 Phosdrin (CAS# 7786-34-7)
B-23 TEDP (CAS# 3689-24-5)
B-24 TEPP (CAS# 107-49-3)
B-25 Chlordane (CAS# 57-74-9)

Public Comment Period

Comments will be accepted until 5:00 p.m. EST on January 21, 2014.

Written comments, identified by CDC-2013-0022 and docket number NIOSH 153-B, may be submitted by any of the following methods:

  • Federal rulemaking portal: Follow the instructions for submitting comments.

    Instructions: All submissions received must include the agency name and docket number [CDC-2013-0022; NIOSH 153-B]. All relevant comments, including any personal information provided, will be posted without change to

  • Mail: NIOSH Docket Office
    Robert A. Taft Laboratories
    4676 Columbia Parkway
    Cincinnati, OH 45226